XML 71 R45.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity - Summary of Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Oct. 23, 2024
Dec. 31, 2024
Dec. 31, 2023
Number of shares      
Assumed stock option grants (in shares)   7,043,587  
Weighted- average exercise price per share      
Assumed stock option grants (in dollars per share)   $ 2.10  
Aggregate intrinsic value      
Share-based compensation vested (in shares) 7,029,124    
Share-based compensation non vested (in shares) 14,463    
Stock options      
Number of shares      
Outstanding, beginning balance (in shares)   12,812,942  
Granted (in shares)   0  
Exercised (in shares)   (1,742,299)  
Expired / forfeited (in shares)   (66,121)  
Outstanding, ending balance (in shares)   18,048,109 12,812,942
Vested and exercisable (in shares)   15,975,885  
Vested and expected to vest (in shares)   18,048,109  
Weighted- average exercise price per share      
Outstanding beginning balance (in dollars per share)   $ 1.43  
Granted (in dollars per share)   0  
Exercised (in dollars per share)   0.06  
Expired / forfeited (in dollars per share)   2.23  
Outstanding ending balance (in dollars per share)   1.82 $ 1.43
Vested and exercisable (in dollars per share)   1.75  
Vested and expected to vest (in dollars per share)   $ 1.82  
Weighted- average remaining contractual term (in years)      
Weighted- average remaining contractual term (in years)   6 years 1 month 6 days 6 years 3 months 18 days
Vested and exercisable (in years)   6 years  
Vested and expected to vest (in years)   6 years 1 month 6 days  
Aggregate intrinsic value      
Average intrinsic value, beginning balance   $ 49,466  
Average intrinsic value, ending balance   19,839 $ 49,466
Vested and exercisable   19,007  
Vested and expected to vest   $ 19,839